Search Results 71-80 of 19697 for autoimmune hepatitis
The purpose of this study aims to investigate the efficacy and safety of survodutide administered once weekly vs. placebo on liver-related outcome events and ...
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers also are making ...
This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.
Specialized treatment for patients with immune-mediated liver disease, such as primary biliary cirrhosis, autoimmune hepatitis and primary sclerosing ...
Autoimmune hepatitis (liver inflammation) or; Human immunodeficiency virus (HIV) infection or; Kidney disease, severe or; Liver or other organ transplant or ...
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world. Learn more from Mayo Clinic.
Liver Disease: A Paradigm for Understanding Environment-Epigenome Interaction ... Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death ...
The best ways to prevent fatty liver disease include the following: Work with your health care team to manage your blood sugar. Lose weight if you need to, and ...
Nonalcoholic fatty liver disease · Autoimmune hepatitis, primary sclerosing cholangitis and immunoglobulin G4 associated cholangitis: the spectrum of autoimmune ...
Mayo researchers were among the first to identify metabolic dysfunction-associated steatotic liver disease and primary sclerosing cholangitis. Mayo researchers ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.